Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect

<p>Abstract</p> <p>Introduction</p> <p>Radioiodine (<sup>131</sup>I) therapy is widely accepted as an essential part of therapeutic regimens in many cases of differentiated thyroid cancer. Radiation-induced oxidative damage to macromolecules is a well known...

Full description

Bibliographic Details
Main Authors: Makarewicz Jacek, Lewiński Andrzej, Karbownik-Lewińska Małgorzata
Format: Article
Language:English
Published: BMC 2010-10-01
Series:Thyroid Research
Online Access:http://www.thyroidresearchjournal.com/content/3/1/7
id doaj-988c366d6be04330a1a133977a8621c5
record_format Article
spelling doaj-988c366d6be04330a1a133977a8621c52020-11-25T01:32:31ZengBMCThyroid Research1756-66142010-10-0131710.1186/1756-6614-3-7Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effectMakarewicz JacekLewiński AndrzejKarbownik-Lewińska Małgorzata<p>Abstract</p> <p>Introduction</p> <p>Radioiodine (<sup>131</sup>I) therapy is widely accepted as an essential part of therapeutic regimens in many cases of differentiated thyroid cancer. Radiation-induced oxidative damage to macromolecules is a well known phenomenon. Frequently examined process to evaluate oxidative damage to macromolecules is lipid peroxidation (LPO), resulting from oxidative damage to membrane lipids. The aim of the study was to examine serum LPO level in hypothyroid (after total thyroidectomy) cancer patients subjected to ablative activities of <sup>131</sup>I.</p> <p>Materials and methods</p> <p>The study was carried out in 21 patients (18 females and 3 males, average age 52.4 ± 16.5 years) after total thyroidectomy for papillary (17 patients) or follicular (4 patients) thyroid carcinoma. Hypothyroidism was confirmed by increased TSH blood concentration (BRAHMS, Germany), measured before <sup>131</sup>I therapy. Activity of 2.8 - 6.9 GBq of <sup>131</sup>I was administered to the patients orally as sodium iodide (OBRI, Poland). Concentrations of malondialdehyde + 4-hydroxyalkenals (MDA + 4-HDA), as an index of LPO (LPO-586 kit, Calbiochem, USA), were measured in blood serum just before <sup>131</sup>I administration (day "0") and on the days 1-4 after <sup>131</sup>I therapy. Sera from 23 euthyroid patients served as controls. Correlations between LPO and TSH or <sup>131</sup>I activity were calculated.</p> <p>Results</p> <p>Expectedly, serum LPO level, when measured before <sup>131</sup>I therapy, was several times higher (p < 0.00001) in cancer patients than in healthy subjects, which is probably due to hypothyroidism caused by total thyroidectomy. However, we did not observe any differences between LPO levels after and before <sup>131</sup>I therapy. LPO did not correlate with TSH concentration. In turn, negative correlation was found between <sup>131</sup>I activity and LPO level on the day "2" after radioiodine treatment.</p> <p>Conclusions</p> <p>Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids, at least early, after therapy.</p> http://www.thyroidresearchjournal.com/content/3/1/7
collection DOAJ
language English
format Article
sources DOAJ
author Makarewicz Jacek
Lewiński Andrzej
Karbownik-Lewińska Małgorzata
spellingShingle Makarewicz Jacek
Lewiński Andrzej
Karbownik-Lewińska Małgorzata
Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
Thyroid Research
author_facet Makarewicz Jacek
Lewiński Andrzej
Karbownik-Lewińska Małgorzata
author_sort Makarewicz Jacek
title Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
title_short Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
title_full Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
title_fullStr Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
title_full_unstemmed Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
title_sort radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids - early effect
publisher BMC
series Thyroid Research
issn 1756-6614
publishDate 2010-10-01
description <p>Abstract</p> <p>Introduction</p> <p>Radioiodine (<sup>131</sup>I) therapy is widely accepted as an essential part of therapeutic regimens in many cases of differentiated thyroid cancer. Radiation-induced oxidative damage to macromolecules is a well known phenomenon. Frequently examined process to evaluate oxidative damage to macromolecules is lipid peroxidation (LPO), resulting from oxidative damage to membrane lipids. The aim of the study was to examine serum LPO level in hypothyroid (after total thyroidectomy) cancer patients subjected to ablative activities of <sup>131</sup>I.</p> <p>Materials and methods</p> <p>The study was carried out in 21 patients (18 females and 3 males, average age 52.4 ± 16.5 years) after total thyroidectomy for papillary (17 patients) or follicular (4 patients) thyroid carcinoma. Hypothyroidism was confirmed by increased TSH blood concentration (BRAHMS, Germany), measured before <sup>131</sup>I therapy. Activity of 2.8 - 6.9 GBq of <sup>131</sup>I was administered to the patients orally as sodium iodide (OBRI, Poland). Concentrations of malondialdehyde + 4-hydroxyalkenals (MDA + 4-HDA), as an index of LPO (LPO-586 kit, Calbiochem, USA), were measured in blood serum just before <sup>131</sup>I administration (day "0") and on the days 1-4 after <sup>131</sup>I therapy. Sera from 23 euthyroid patients served as controls. Correlations between LPO and TSH or <sup>131</sup>I activity were calculated.</p> <p>Results</p> <p>Expectedly, serum LPO level, when measured before <sup>131</sup>I therapy, was several times higher (p < 0.00001) in cancer patients than in healthy subjects, which is probably due to hypothyroidism caused by total thyroidectomy. However, we did not observe any differences between LPO levels after and before <sup>131</sup>I therapy. LPO did not correlate with TSH concentration. In turn, negative correlation was found between <sup>131</sup>I activity and LPO level on the day "2" after radioiodine treatment.</p> <p>Conclusions</p> <p>Radioiodine remnant ablation of differentiated thyroid cancer does not further increase oxidative damage to membrane lipids, at least early, after therapy.</p>
url http://www.thyroidresearchjournal.com/content/3/1/7
work_keys_str_mv AT makarewiczjacek radioiodineremnantablationofdifferentiatedthyroidcancerdoesnotfurtherincreaseoxidativedamagetomembranelipidsearlyeffect
AT lewinskiandrzej radioiodineremnantablationofdifferentiatedthyroidcancerdoesnotfurtherincreaseoxidativedamagetomembranelipidsearlyeffect
AT karbowniklewinskamałgorzata radioiodineremnantablationofdifferentiatedthyroidcancerdoesnotfurtherincreaseoxidativedamagetomembranelipidsearlyeffect
_version_ 1725081519645523968